Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal cell wall is a complex and dynamic structure essential for the survival, growth, and virulence of fungal pathogens. It is primarily composed of a cross-linked network of polysaccharides, including chitin, beta-glucans (specifically 1,3-beta-D-glucan and 1,6-beta-D-glucan), and various mannoproteins [1][2]. These components provide the necessary mechanical strength to withstand high internal osmotic pressure and protect the cell from environmental stressors. Because these specific carbohydrate polymers are absent in human cells, the fungal cell wall represents a highly selective target for antifungal therapy [3]. Drugs such as echinocandins (e.g., caspofungin) and the triterpenoid ibrexafungerp exert their fungicidal effects by inhibiting the synthesis of 1,3-beta-D-glucan, leading to cell wall instability and osmotic lysis [3][4]. Additionally, cell wall components like galactomannan and beta-glucan are shed into the host's bloodstream during invasive infections, serving as critical diagnostic biomarkers for early detection and monitoring of treatment efficacy [2][5]. (Citations: [1] Gow et al., 2017, Nature Reviews Microbiology; [2] Garcia-Rubio et al., 2020, Microorganisms; [3] StatPearls, 2023, Antifungal Medications; [4] NIH/NCBI, 2021, Beta-glucan Synthase Inhibitors; [5] CDC, 2022, Laboratory Diagnosis of Fungal Infections).
Inhibition of 1,3-beta-glucan synthase; Inhibition of chitin synthase; Disruption of cell wall polymer cross-linking
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal cell wall components.